Yash Gupta Equity Research Associate, Angel Broking
Pharma Majors – Cipla, Dr Reddy’s, Sun Pharma, Torrent Pharma and Emcure are collaborating for the Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for treatment of mild COVID-19 patients in India. As per the directive of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization, Dr. Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr Reddy’s in its clinical trial.
Though the Covid cases in India are stabilizing at 50,000 cases per day, the fear of 3rd wave and Delta plus variants cannot be ruled out. This drug will help the mild cases of Covid to be treated at home and decrease the requirement of hospitalization in such cases. This is positive for all the companies.
